Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagio Medical Holdings (ADGM) Common Equity (2023 - 2025)

Adagio Medical Holdings (ADGM) has disclosed Common Equity for 3 consecutive years, with $12.4 million as the latest value for Q4 2025.

  • Quarterly Common Equity changed N/A to $12.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.4 million through Dec 2025, changed N/A year-over-year, with the annual reading at $12.4 million for FY2025, N/A changed from the prior year.
  • Common Equity for Q4 2025 was $12.4 million at Adagio Medical Holdings, up from -$1.3 million in the prior quarter.
  • The five-year high for Common Equity was $76.6 million in Q3 2024, with the low at -$140.5 million in Q2 2024.
  • Average Common Equity over 3 years is -$47.4 million, with a median of -$1.3 million recorded in 2025.
  • The sharpest move saw Common Equity soared 161.99% in 2024, then tumbled 101.71% in 2025.
  • Over 3 years, Common Equity stood at -$132.0 million in 2023, then skyrocketed by 157.99% to $76.6 million in 2024, then plummeted by 83.8% to $12.4 million in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at $12.4 million, -$1.3 million, and $8.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.